Toplines: National Survey of Pharmacists, Findings on Medicare Part D
These toplines provide the results of a 2006 national survey of pharmacists on their views and experiences related to the new Medicare drug benefit. Topline (.
View the Latest: Prescription Drugs
Filter
-
-
National Surveys of Pharmacists and Physicians, Findings on Medicare Part D
Poll FindingTwo national surveys conducted and analyzed by the Kaiser Family Foundation show that substantial majorities of pharmacists and physicians believe that the prescription drug law is helping people on Medicare save money on their medications.
-
The Role of Part D for People With HIV/AIDS: Coverage and Cost of Antiretrovirals Under Medicare Drug Plans
Issue BriefThe Kaiser Family Foundation released a new report on the implications of the new Medicare Part D prescription drug benefit for people living with HIV/AIDS. The report looks at the coverage and cost of antiretroviral drugs under the new private, stand-alone Medicare drug plans. Report (.
-
Observations on the Initial Implementation of the Medicare Prescription Drug Program: Perspectives of State Medicaid Directors Through a Focus Group Discussion
ReportObservations on the Initial Implementation of the Medicare Prescription Drug Program: Perspectives of State Medicaid Directors Through a Focus Group Discussion Medicaid directors express the need to continue to focus on the interaction between Medicaid and the Medicare prescription drug benefit and to address the key system and coordination issues that remain, particularly with the…
-
Illustrating the Potential Impacts of Adverse Selection on Health Insurance Costs in Consumer Choice Models
Other PostHealth Care Spending in the United States and OECD Countries Health spending is rising faster than incomes in most developed countries, which raises questions about how these countries will pay for future health care needs.
-
Medicare Part D Data Spotlight: A First Look at Part D Plan Offerings in 2012
ReportThis data spotlight examines the stand-alone Part D drug plan options available to Medicare beneficiaries in 2012. Medicare beneficiaries will, on average, be able to choose from 31 stand-alone Medicare Part D prescription drug plans to choose from, a new Kaiser analysis finds.
-
The Role of Clinical and Cost Information in Medicaid Pharmacy Benefit Decisions: Experience in Seven States
Issue BriefThis policy brief provides perspective on the potential for using comparative effectiveness research in Medicaid pharmacy programs by looking at seven states to determine how they currently evaluate relative clinical and cost information about prescription drugs when making coverage decisions for their Medicaid pharmacy benefits.
-
Hispanics and the New Medicare Drug Benefit
Poll FindingIn a few short weeks, Medicare will undergo big changes that will have a major impact on more than 3 million Hispanic seniors and younger people with permanent disabilities who rely on Medicare for their health coverage.
-
Medicare Part D 2010 Data Spotlight: Benefit Design and Cost Sharing
ReportThe Medicare Modernization Act established a defined standard drug benefit for Part D stand-alone Prescription Drug Plans (PDPs) and Medicare Advantage Prescription Drug (MA-PD) plans, while giving plans flexibility to offer alternative benefit designs. Only about one in 10 PDPs offer the standard benefit in 2010.
-
An Implementation Perspective on Part D, the Medicare Prescription Drug Program
ReportThis focus group of 12 state Medicaid officials conducted in November 2005 explores the current status and likely results of the Part D dual eligible transition efforts as well as other Part D-related issues of particular importance to states.